Objective-To examine the proangiogenic potential of myofibroblasts and mast cells, 2 types of cells present in human aortic valves. Methods and Results-Aortic valve stenosis is an active atheroinflammatory disease, characterized by the accumulation of inflammatory cells and the neovascularization of the valves. A total of 85 stenotic valves and 20 control valves were obtained during valve replacement surgery. The results of immunohistochemistry analysis revealed stenotic aortic valves that contained 3 types of neovessels: small microvessels, medium microvessels, and organized arterioles. The distribution density of the neovessels was significantly higher in stenotic valves than in control valves (PϽ0.001) and correlated positively with valvular calcification gradus (rϭ0.26, Pϭ0.02) and mast cell density (rϭ0.38, PϽ0.001). In the neovascularized areas of stenotic aortic valves, mast cells contained vascular endothelial growth factor and were degranulated, indicating their activation. The stimulation of cultured myofibroblasts derived from aortic valves with a mast cell-preconditioned medium, hypoxic culture conditions, or tobacco smoke all induced vascular endothelial growth factor secretion in the myofibroblasts. Finally, mast cell tryptase was able to degrade the antiangiogenic molecule endostatin in vitro.
A ortic valve stenosis (AS) is an actively regulated fibrocalcific disease with a rapidly increasing prevalence as the result of the aging of the population. 1 It has many similarities to arterial atherosclerosis, including common risk factors such as hypercholesterolemia, hypertension, age, diabetes mellitus, male sex, and cigarette smoking. [2] [3] [4] A key event in the development of AS is active calcification and osteoblast-like bone formation, [5] [6] [7] [8] accompanied by extracellular matrix remodeling and valvular accumulation of lipids and inflammatory cells, such as mast cells. 9 -11 During the disease process, the valvular resident cells (ie, the myofibroblasts) assume a state of long-term activation and proliferation. 12 Again, activation of the myofibroblasts contributes to adverse changes in matrix turnover 13 and, ultimately, in pathological valve leaflet thickening.
In contrast to healthy avascular aortic valves, both nonrheumatic and rheumatic stenotic aortic valves show marked neovascularization. 5, 14 Although the significance of valvular neovascularization is being debated, it has been proposed that neovessels may facilitate the entry of inflammatory cells and lipids into the leaflets, thus accelerating disease progression. 15 Indeed, the presence of neovessels correlates with the degree of valvular inflammation and calcification, 16, 17 suggesting that neoangiogenesis could provoke an adverse response in the diseased leaflets.
Previous investigations have described the presence of both angiogenic and antiangiogenic mediators in stenotic aortic valves. One of the most potent proangiogenic factors, vascular endothelial growth factor (VEGF) (or VEGF-A), and its receptors, VEGF receptor 1 (VEGFR-1) and VEGFR-2, are all locally expressed in aortic valves and upregulated in stenotic valves. 16 In addition to VEGF, proangiogenic secreted protein, acidic and rich in cysteine/osteonectin (also known as SPARC) is upregulated, 18 whereas antiangiogenic chondromodulin-I, is downregulated in stenotic aortic valves. 19 Another antiangiogenic factor, endostatin, which potently hinders angiogenesis by inhibiting endothelial cell proliferation, 20 is also present in stenotic aortic valves 21 ; however, the regulation of its activity in the valves remains enigmatic.
Possible sources of VEGF in aortic valves include endothelial cells and myofibroblasts. 14, 16 Indeed, a recent study 22 suggests that myofibroblasts in stenotic aortic valves are angiogenically active. In addition, mast cells, which have been shown to release VEGF on activation 23 and to promote neovascularization in malignant tumors, 24 may also participate in neovessel formation in stenotic valves. Although mast cells are abundantly present in diseased valves, 10 their angiogenic potential in aortic valves is unclear. Thus, the aim of our study was to analyze the possible effect of activated myofibroblasts and activated mast cells in valvular angiogenesis using both immunohistochemical and cell culture methods.
Methods
We obtained stenotic aortic valves from 85 patients undergoing valve replacement surgery as the result of symptomatic and severe AS ( Supplemental Table I and Supplemental Table II ; available online at http://atvb.ahajournals.org). Neovessels and mast cells were counted from immunostained cryostat sections by light microscopy in the 85 stenotic valves and the 20 control valves. The cross-sectional areas, and the amounts and proportions of positive staining in immunohistochemical and double immunofluorescence studies, were measured by computer-assisted morphometry. Subcellular distribution of tryptase and VEGF in mast cells was visualized using confocal microscopy.
Myofibroblasts were isolated from aortic valves obtained at valve replacement surgery, and the myofibroblast phenotype was confirmed by immunohistochemistry ( Supplemental Tables III, IV The effect of aortic valve myofibroblasts on cultured human mast cells was studied by incubating the mast cells with or without myofibroblast-conditioned media. We also incubated human recombinant endostatin with or without mast cell tryptase; protein frag-mentation was detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Statistical analyses were performed using SPSS for Windows software (SPSS Inc, Cary, North Carolina). For a more detailed "Methods" section, please see the Supplemental Material (available online at http://atvb.ahajournals.org).
Results

Immunohistochemistry
In immunohistochemical stainings, neovascularization was detectable in 80 (94%) of the 85 stenotic aortic valves. The neovessels were typically located in the vicinity of calcific nodules; they were also close to the valve surface and other cell-rich areas. In contrast, neovessels were visible in only 2 (10%) of the 20 control valves in which vessels were not observed in the leaflets themselves; rather, they were at their aortic interfaces. In the stenotic valves, we identified 3 types of neovessels: small microvessels, with 1 to 2 cross-sectional endothelial cells around a small lumen; medium microvessels, with more than 2 cross-sectional endothelial cells around a larger lumen; and arterioles, with an organized ␣-actinpositive vessel wall ( Figure 1A -C). Some of the small and medium microvessels, and all of the arterioles, were surrounded by pericytes ( Figure 1D and E). In the 2 control valves, only small microvessels were observable. The density of the neovessels was considerably higher in the stenotic aortic valves versus the control valves ( Figure 2A ). The densities of the 3 vessel types correlated positively with mast cell densities in the stenotic aortic valves (rϭ0.29, Pϭ0.007; rϭ0.39, PϽ0.001; rϭ0.36, PϽ0.001; and rϭ0.38, PϽ0.001 for small microvessels, medium microvessels, arterioles, and all vessels, respectively) ( Figure 2B ). The amount of valvular myofibroblasts was higher in the stenotic versus the control valves ( Figure 2C ), and it correlated positively with the densities of small microvessels, medium microvessels, and all vessels (rϭ0.60, Pϭ0.006; rϭ0.74, PϽ0.001; and rϭ0.72, PϽ0.001, respectively) ( Figure 2D ). In the stenotic aortic valves, there was also a positive correlation between the level of calcification (grades 1 to 4) and the densities of medium microvessels (rϭ0.29, Pϭ0.007), arterioles (rϭ0.37, PϽ0.001), and all neovessels (rϭ0.26, Pϭ0.02), but not with the density of the small microvessels (rϭ0.20, Pϭ0.07) ( Figure 3 ). In statistical analyses, none of the described parameters demonstrated differences between bicuspid and tricuspid valves.
Double Immunofluorescence
Double immunofluorescence stainings revealed that the neovessels in the stenotic aortic valves resided in mast cell-rich areas ( Figure 4A -C), with 83% of the mast cells being adjacent to a neovessel (Ͻ50 m). In stenotic valves, almost every mast cell was activated (ie, degranulated), and most of them (62%) stained positively for VEGF. Moreover, the results of an examination of activated mast cells by confocal microscopy revealed VEGF-positive extracellular granules, indicating active release of this proangiogenic mediator by valvular mast cells ( Figure 4D -F). Positive VEGF staining was also evident in myofibroblasts (48%) and endothelial cells, both in those on the valve surface (90%) and the neovessels (58%) ( Figure 4G -O). The endothelial cells lining the valve were also positive for VEGF in the control valves. In these valves, some VEGF-positive resting mast cells were visible subendothelially (data not shown).
VEGF Secretion by Cultured Aortic Valve Myofibroblasts
Because VEGF was immunohistochemically detectable only in a fraction of valvular myofibroblasts, we explored how certain stimuli potentially present in diseased valves in vivo might alter VEGF expression in cultured aortic valve myofibroblasts. For this purpose, we investigated the effects of selected local factors linked to the pathogenesis of AS, including mast cell-derived components, hypoxia, and osteogenic stress. In addition, we tested the effect of statin as a potential protective factor; and the effect of tobacco smoke, an external risk factor of AS that promotes valvular tissue remodeling and inflammation. 25, 26 We found that cultured aortic valve myofibroblasts secreted VEGF into cell culture media constitutively, and that mast cell-derived components, among them tumor necrosis factor ␣, induced a significant increase in VEGF secretion by such myofibroblasts. Furthermore, hypoxic conditions and tobacco smoke evoked a similar response ( Figure 5A-D) . Introducing the myofibroblasts to an osteogenic stress resulted in decreased VEGF secretion ( Figure 5E ), consistent with early osteogenic differentiation. 27 The VEGF responses of control myofibroblasts, derived from nonstenotic aortic valves, were similar to those of cells from stenotic aortic valves, with the exception of relatively higher VEGF secretion by the control cells after 48 hours of incubation with tumor necrosis factor ␣ (Pϭ0.01) (Supplemental Figure III) . The effects of both tobacco smoke and tumor necrosis factor ␣ were also detectable at the mRNA level ( Figure 5F ). In contrast, the administration of lovastatin to the cells had virtually no effect on their VEGF secretion (data not shown).
VEGF Secretion by Cultured Mast Cells
To study the potential effects of myofibroblasts on mast cells in the aortic valve, we incubated human mature mast cells (generated from circulating mast cell progenitors) with conditioned media obtained from stenotic aortic valve myofibroblasts. Interestingly, the myofibroblast-conditioned medium significantly increased VEGF secretion by the mast cells ( Figure 5G ). Only a minor effect was observable after 1 hour of incubation, revealing de novo synthesis and prolonged secretion of VEGF rather than immediate release with mast cell granules.
Endostatin Degradation by Tryptase
To study the effect of mast cell tryptase on endostatin, purified human endostatin was incubated with mast cell tryptase for various periods and intact endostatin was visualized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. As shown in Figure 6 , after incubation with tryptase, a clear diminution of the intensity of the endostatin band was visible, indicating proteolytic loss of intact endostatin.
Discussion
The results of the present study are congruent with the previous investigations 5, 16, 17 showing that neovascularization is a manifest histological change in patients with AS. As a novel aspect, this study raises the possibility that mast cells, together with myofibroblasts, are pathogenic players in valve neoangiogenesis. Indeed, the results reveal that mast cells may participate in valve neovascularization by several mechanisms. First, valvular mast cells stored and secreted proangiogenic VEGF; the observable close proximity of mast cells and neovessels allows mast cell-derived compounds to rapidly reach neovessels and their surroundings. Second, mast cells and their constituents, including tumor necrosis factor ␣, were able to evoke VEGF secretion in aortic valve myofibroblasts. Third, mast cell-derived tryptase could also accelerate valvular neovascularization by degrading the antiangiogenic endostatin. Finally, the spatial association of mast cells and neovessels enables the actions of mast cell-derived proteases on the extracellular matrix to facilitate neovessel growth. Indeed, mast cells in stenotic aortic valves have previously been shown to secrete tryptase, chymase, and cathepsin G, 10, 25 suggesting that they participate in the degradation of the extracellular matrix, a process necessary for microvessel formation. 28 More important, the mast cells in stenotic aortic valves contained VEGF-positive cytoplasmic granules and were degranulated (ie, they had released VEGF into their microenvironment). In addition, the experiments with cultured mast cells revealed that mast cells secrete VEGF constitutively and that they may interact with valvular myofibroblasts to promote local angiogenesis because myofibroblast-derived components were able to provoke VEGF secretion by human mast cells. Interestingly, this occurred in the absence of mast cell degranulation, suggesting that other mast cell-activating mechanisms are responsible for the observed release of VEGF-containing granules in the diseased valves ( Figure 4D-F) .
The myofibroblasts in stenotic aortic valves express both VEGF and its receptors VEGFR-1 and VEGFR-2 and also participate in adverse extracellular matrix remodeling in the diseased leaflets. 16, 25, 29 Our present observations reveal that valvular myofibroblasts may enhance their VEGF secretion in response to local inflammation, notably activated mast cells. Furthermore, hypoxia and tobacco smoke also stimulated VEGF secretion by cultured aortic valve myofibroblasts. Smoking has been shown to associate with a higher collagen to elastin ratio in aortic valves. 25 The soluble components of tobacco smoke can activate mast cells, provoke profibrotic activity in fibroblasts, 25 and induce an inflammatory response in valvular myofibroblasts. 26 Accordingly, external risk factors of AS, such as smoking, may contribute to a self-perpetuating process in which myofibroblasts and mast cells are activated, resulting in a fibrotic response in the leaflets. The ensuing hypoxia in the thickened leaflets would then further promote VEGF secretion and neovessel formation that, again, by supplying oxygen to myofibroblasts and mast cells would enable their proliferation and activation. Conceivably, valvular thickening, inflammation, calcification, and angiogenesis could, once initiated, also be simultaneously ongoing processes eventually resulting in the progression of aortic stenosis, rather than angiogenesis having a direct causal effect on it.
In this study, we divided the neovessels into 3 subgroups by their size and shape. Small microvessels are likely to be most recently formed because they were also visible in some control valves, whereas fully developed arterioles probably represent more advanced lesions. In support of this concept, the density of organized arterioles correlated strongly with the degree of valvular calcification, a sign of an advanced lesion also shown to correlate with the patient's prognosis. 30 Vessel maturity can also be defined by the presence of pericytes. 31 Indeed, in stenotic aortic valves, a noticeable number of neovessels were surrounded by pericytes, most of them being medium microvessels and arterioles. Thus, most valvular microvessels could be classified as primitive by this criterion.
Like in human atherosclerotic lesions, 32 neovascularization in the thickened aortic valves could both suppress and provoke disease progression. By providing oxygen and nutrients to the deeper parts of a hypertrophied valve leaflet, neovascularization could act to prevent cellular necrosis and the formation of necrotic core areas. On the other hand, by facilitating the transport of inflammatory cells and lipids into the leaflets, neovascularization could accelerate valvular thickening and calcification. Neovascular endothelium secretes angiogenic mediators, including VEGF, which may exert effects on osteogenic cells, 33 and thereby induce ectopic calcification. Moreover, neovascular pericytes may act as osteogenic progenitors, thus contributing to the calcification process. 33 In contrast to advanced atherosclerotic lesions, in which intraplaque hemorrhages are a common finding, 32 neovessel ruptures were extremely rare in the stenotic valves examined in our study. Thus, the role of neovascularization may not be identical in these 2 types of atheroinflammatory lesions.
Although of debatable outcome, valvular neovascularization is likely to portray disease activity. The concept of neovessels indicating disease severity in patients with AS raises interesting options for future disease monitoring. Accordingly, in addition to measuring clinical outcomes and progression of the disease using echocardiography, future studies on patients with AS should also target assessing the progression of the disease process in the aortic valve itself. It is tempting to hypothesize that advanced imaging technologies could allow direct visualization of the valve pathology in vivo. Indeed, some promising data on detecting valvular angiogenesis have already become available in an experimental animal model. 34 Provided that the growth of neovessels represents an indicator of disease activity, the quantification of valvular angiogenesis could aid in patient follow-up and even in the selection of treatment options.
The only effective treatment of AS is still valve replacement surgery, which has driven the vigorous search for possible pharmacological targets. Interestingly, statin therapy has been associated with a reduced vascular density in the valves, 16 and experimental studies [35] [36] [37] involving statins demonstrate several potential disease-hindering mechanisms. We found no significant differences in the densities of valvular neovessels in relation to statin use. However, only 17 of the 85 patients were taking statins, and the use of drugs was not monitored. Lovastatin had no influence on VEGF secretion by valvular myofibroblasts either, which also speaks against statins preventing valvular neoangiogenesis. Considering the Figure 5 . VEGF secretion by myofibroblasts derived from stenotic aortic valves (A through F) and human mast cells (G). Secretion by the myofibroblasts was increased in response to mast cellconditioned media (MC-stimulated) (A), tumor necrosis factor (TNF) ␣ (B), hypoxia (C), and tobacco smoke (D); and was decreased in response to osteogenic stress (OG stress) (E). A similar response to tobacco smoke and TNF-␣ was seen at the mRNA level (F). The valvular myofibroblast-conditioned medium was able to increase VEGF secretion by the mast cells (G). Results are presented as medians and interquartile ranges (A through E) or meanϮSD (F through G). mainly negative results from recent controlled trials 38 -40 on statins in patients with AS, either the alternative timing of treatment or a fully different pharmacological approach needs to be contemplated. New findings suggest that mast cells may serve as a novel therapeutic target for cancer treatment and that inhibiting mast cell function may even lead to tumor regression. 41 In the aortic valve, stabilizing mast cells may antagonize not only neovascularization but also adverse tissue remodeling, including fibrosis and elastin degradation. 10, 25 Regarding neovascularization, anti-inflammatory tetracycline derivatives have been suggested to affect aortic valve tissue, 1 of the effects being reduction of local VEGF production. 42 Endostatin, an endogenous inhibitor of angiogenesis already used as a drug against tumor growth, 43 could also have some potential prospects in the field of AS prevention. However, more thorough knowledge of the significance of neovascularization in patients with AS is essential before neovessel-targeting agents can be entertained as treatment options for this complex disease. Figure 6 . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed after incubating endostatin with or without tryptase for 0 to 24 hours. A, The endostatin band remains intact in the control samples. B, In the tryptaseincubated samples, band intensity decreases in a timedependent manner, and a second lower band becomes visible, denoting degradation. The upper bands represent tryptase.
